Twenty years ago, drug discovery ran on a simple script of screening compounds and hoping for a hit. This exclusive ebook, Where Drug Discovery Goes Next, captures how far the field has come and where it is heading. Inside, ELRIG scientific advisory board member Saleha Patel shares what two decades across pharma, academia, and biotech taught her about data quality, collaboration, and career design. The collection also explores how developers are making ex vivo CAR T manufacturing faster and more reproducible, how a triple drug therapy cleared an HIV-like virus in infant rhesus macaques, and why outcome-first screening could surface molecular glue degraders that narrower screens miss. Together, these stories show a field learning to move faster while keeping the science rigorous and practically usable.
Key Learning Objectives:
- The two decades of change that got us here
- The technologies, modalities and trends defining the field today
- The outlook from leading researchers and developers